# INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY

Source: https://onco.cc/trials/nct07430696/  
OnCo record `nct07430696` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by University of Kelaniya, not yet recruiting.

## Summary

INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY is a phase 2, randomised interventional study registered as NCT07430696 by University of Kelaniya, with a registry enrolment figure of 40 participants, started 2026-05-01 and due to reach its primary completion in 2027-05-01. Interventions recorded: Trishul 750 mg bd orally. Conditions listed: Efficacy of Trishul. Primary outcome: Overall survival; Overall survival. Colorectal eligibility wording from the registry: "* Histologically confirmed diagnosis of adenocarcinoma of the rectum stratified for grade of tumour of biopsy samples (Grade 1 and 11 vs 111)". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07430696
- Phase: 2
- Setting: INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY
- Sponsor: University of Kelaniya
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT07430696: https://clinicaltrials.gov/study/NCT07430696

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07430696.json